Basile, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 3.763
AS - Asia 2.923
EU - Europa 2.221
SA - Sud America 523
AF - Africa 75
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.524
Nazione #
US - Stati Uniti d'America 3.629
SG - Singapore 1.392
CN - Cina 623
SE - Svezia 520
BR - Brasile 438
IT - Italia 422
VN - Vietnam 296
DE - Germania 283
FR - Francia 235
PL - Polonia 137
GB - Regno Unito 134
IE - Irlanda 126
IN - India 118
FI - Finlandia 89
JP - Giappone 89
BD - Bangladesh 82
ID - Indonesia 81
RU - Federazione Russa 66
CA - Canada 63
HK - Hong Kong 57
MX - Messico 50
UA - Ucraina 36
TR - Turchia 34
NL - Olanda 31
AR - Argentina 28
KR - Corea 28
ZA - Sudafrica 25
ES - Italia 23
BE - Belgio 22
IQ - Iraq 20
AT - Austria 14
CZ - Repubblica Ceca 13
MA - Marocco 13
SA - Arabia Saudita 13
CO - Colombia 10
JO - Giordania 10
LT - Lituania 10
AU - Australia 9
CL - Cile 9
EC - Ecuador 9
IR - Iran 9
TN - Tunisia 9
VE - Venezuela 9
CH - Svizzera 8
CI - Costa d'Avorio 8
MY - Malesia 8
NZ - Nuova Zelanda 8
PE - Perù 8
PT - Portogallo 8
KE - Kenya 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
BY - Bielorussia 6
DK - Danimarca 6
DZ - Algeria 6
GR - Grecia 6
JM - Giamaica 6
LB - Libano 6
PK - Pakistan 6
PY - Paraguay 6
KZ - Kazakistan 4
PH - Filippine 4
RO - Romania 4
AL - Albania 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
LV - Lettonia 3
MM - Myanmar 3
OM - Oman 3
AZ - Azerbaigian 2
BO - Bolivia 2
CG - Congo 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
NP - Nepal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
EU - Europa 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
Totale 9.515
Città #
Singapore 833
Chandler 492
Ashburn 422
San Jose 366
New York 174
Beijing 133
Dublin 125
Warsaw 123
Los Angeles 99
Ho Chi Minh City 98
The Dalles 97
Rome 96
Dallas 95
Tokyo 86
Hefei 77
Council Bluffs 76
Lauterbourg 74
Jakarta 73
Frankfurt am Main 72
Hanoi 64
San Mateo 62
Helsinki 61
Boston 53
Fairfield 52
Munich 51
Hong Kong 50
São Paulo 50
North Bergen 47
Wilmington 47
Milan 46
Marseille 42
Princeton 42
Houston 39
Moscow 39
Boardman 37
Orem 35
Ann Arbor 30
Nanjing 30
Seattle 30
Jacksonville 29
Cattolica 28
London 27
Santa Clara 26
Chicago 24
Hyderabad 24
Seoul 24
Da Nang 23
Paris 23
Atlanta 22
Kent 22
Woodbridge 22
Bremen 21
Dearborn 21
Nuremberg 21
Chennai 20
Mexico City 20
Montreal 20
Redwood City 20
Brooklyn 18
Buffalo 18
Denver 18
Johannesburg 18
Poplar 18
Toronto 18
Brussels 17
Stockholm 17
Amsterdam 15
Rio de Janeiro 15
Bologna 14
Castelnuovo di Val di Cecina 14
Falls Church 14
Phoenix 14
San Francisco 13
Tianjin 13
Guangzhou 12
Haiphong 12
Hebei 12
Norwalk 12
Lappeenranta 11
Querétaro 11
Shenyang 11
Bexley 10
Edinburgh 10
Falkenstein 10
Lancaster 10
Manchester 10
Turku 10
Baghdad 9
Cambridge 9
Nanchang 9
Roubaix 9
Shanghai 9
Abidjan 8
Amman 8
Augusta 8
Belo Horizonte 8
Brno 8
Curitiba 8
Düsseldorf 8
Izmir 8
Totale 5.459
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 342
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 193
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 171
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 170
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 165
Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport 159
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 156
Evaluation of screening method for Bence Jones protein analysis 155
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 154
Immunological role of IgG subclasses 154
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 149
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Overview of immune abnormalities in lysosomal storage disorders 144
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 143
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 142
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 142
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 142
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 141
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 140
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 140
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 137
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 136
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 135
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 134
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 134
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 132
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 128
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 128
Immunological role of IgG subclasses 127
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 126
Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection 125
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 125
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 124
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 123
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 123
Antenna-enhanced mid-infrared detection of extracellular vesicles derived from human cancer cell cultures 122
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 122
SARS-CoV-2 was already circulating in Italy, in early December 2019 122
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 122
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 122
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 122
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity 121
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 120
The Laboratory Role in anti-TNF Biological Therapy Era 120
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 117
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 117
Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease 116
Heavy chain disease: Our experience 110
IgG cryoglobulinemia 110
Serum free light chain quantitative assays: Dilemma of a biomarker 110
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 109
Anti-nuclear antibody detection in cryoprecipitates: Distinctive patterns in hepatitis C virus-infected patients 109
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 105
COVID-19, adaptative immune response and metabolic-associated liver disease 104
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 102
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 102
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 101
Cryoglobulins: putative effectors of adaptive immune response 101
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 101
The dark side of current analytic methods for Bence Jones Proteinuria 100
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 99
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 97
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 96
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 91
Type 2 cytokines and scleroderma interstitial lung disease 91
Free light chains and autoimmunity 88
Calprotectin: two sides of the same coin 85
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 83
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 82
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 81
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 77
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 73
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 71
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 67
SCREENING FOR THE IDENTIFICATION OF AUTOIMMUNE OR LYMPHOPROLIFERATIVE ONSET IN PATIENTS NAiVE TO HCV ANTIVIRAL TREATMENT 63
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 61
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 59
Post-pandemic drug and alcohol-related road accidents analysis in Central Italy area 39
Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort 6
Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease 4
Autoimmune and Inflammatory Diseases: Identifying New Advances in Immunological Insights 1
IgA Subclasses and Free Light Chains in Celiac Disease: A Pilot Study 1
Totale 9.707
Categoria #
all - tutte 40.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022492 23 11 5 72 38 18 12 76 24 22 80 111
2022/20231.395 204 179 90 212 89 151 84 121 148 20 73 24
2023/2024839 35 194 12 85 26 161 67 34 6 43 72 104
2024/20251.729 60 50 118 84 154 95 40 97 248 156 360 267
2025/20264.416 547 121 309 587 818 213 798 206 265 301 164 87
Totale 9.707